LMR Partners’s Histogen Inc. Common Stock HSTO Stock Holding History

LMR Partners’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-364	Closed	-$311K	–	550
2018 Q2	$311K	Buy	+364	New	+$302K	0.02%	347

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LMR Partners's HSTO Position: Q3 2018 in Review

LMR Partners sold out of Histogen Inc. Common Stock (HSTO) in Q3 2018, closing a stake of 364 shares — an estimated $311K sold.

LMR Partners first reported a position in HSTO in Q2 2018 and held it in 1 quarter. The position peaked at $311K in Q2 2018. 55 funds tracked by Wall St. Rank hold HSTO as of Q3 2018.

LMR Partners reported no remaining Histogen Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
LMR Partners sold 364 Histogen Inc. Common Stock shares in Q3 2018, an estimated $311K.
LMR Partners first reported a position in Histogen Inc. Common Stock in Q2 2018 and held it in 1 quarter.
LMR Partners's Histogen Inc. Common Stock position peaked at $311K in Q2 2018.
55 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2018.

Based on LMR Partners's 13F filing for Q3 2018, filed 14 Nov 2018.